Paull KD[au] - Search Results

Year	Number of Results
1968	1
1970	1
1972	2
1974	1
1976	1
1981	1
1982	1
1984	2
1985	3
1986	1
1987	1
1988	3
1989	2
1990	2
1991	1
1992	4
1993	3
1994	6
1995	1
1996	3
1997	4
1998	6
1999	1
2000	1
2024	0

1

Development of human tumor cell line panels for use in disease-oriented drug screening.

Shoemaker RH, Monks A, Alley MC, Scudiero DA, Fine DL, McLemore TL, Abbott BJ, Paull KD, Mayo JG, Boyd MR. Shoemaker RH, et al. Among authors: paull kd. Prog Clin Biol Res. 1988;276:265-86. Prog Clin Biol Res. 1988. PMID: 3051021 Review. No abstract available.

2

Computer-assisted structure-activity correlations.

Nasr M, Paull KD, Narayanan VL. Nasr M, et al. Among authors: paull kd. Adv Pharmacol Chemother. 1984;20:123-90. doi: 10.1016/s1054-3589(08)60266-5. Adv Pharmacol Chemother. 1984. PMID: 6398967 Review.

3

A protein expression database for the molecular pharmacology of cancer.

Myers TG, Anderson NL, Waltham M, Li G, Buolamwini JK, Scudiero DA, Paull KD, Sausville EA, Weinstein JN. Myers TG, et al. Among authors: paull kd. Electrophoresis. 1997 Mar-Apr;18(3-4):647-53. doi: 10.1002/elps.1150180351. Electrophoresis. 1997. PMID: 9150955

4

Computer-assisted structure--antileukemic activity analysis of purines and their aza and deaza analogs.

Narayanan VL, Nasr M, Paull KD. Narayanan VL, et al. Among authors: paull kd. Prog Drug Res. 1990;34:319-41. doi: 10.1007/978-3-0348-7128-0_9. Prog Drug Res. 1990. PMID: 2236568 Review. No abstract available.

5

Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin.

Hamel E, Lin CM, Plowman J, Wang HK, Lee KH, Paull KD. Hamel E, et al. Among authors: paull kd. Biochem Pharmacol. 1996 Jan 12;51(1):53-9. doi: 10.1016/0006-2952(95)02156-6. Biochem Pharmacol. 1996. PMID: 8534268

6

The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets.

Monks A, Scudiero DA, Johnson GS, Paull KD, Sausville EA. Monks A, et al. Among authors: paull kd. Anticancer Drug Des. 1997 Oct;12(7):533-41. Anticancer Drug Des. 1997. PMID: 9365500 Review. No abstract available.

7

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD, Ahn NG, Oskarsson MK, Fukasawa K, Paull KD, Vande Woude GF. Duesbery NS, et al. Among authors: paull kd. Science. 1998 May 1;280(5364):734-7. doi: 10.1126/science.280.5364.734. Science. 1998. PMID: 9563949

8

Bufadienolides. 7. Synthesis of 3-beta-acetoxy-5-alpha,14-alpha-bufa-20,22-dienolide.

Pettit GR, Fessler DC, Paull KD, Hofer P, Knight JC. Pettit GR, et al. Among authors: paull kd. J Org Chem. 1970 May;35(5):1398-404. doi: 10.1021/jo00830a031. J Org Chem. 1970. PMID: 4245393 No abstract available.

9

Mining and visualizing large anticancer drug discovery databases.

Shi LM, Fan Y, Lee JK, Waltham M, Andrews DT, Scherf U, Paull KD, Weinstein JN. Shi LM, et al. Among authors: paull kd. J Chem Inf Comput Sci. 2000 Mar-Apr;40(2):367-79. doi: 10.1021/ci990087b. J Chem Inf Comput Sci. 2000. PMID: 10761142

10

An information-intensive approach to the molecular pharmacology of cancer.

Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD. Weinstein JN, et al. Among authors: paull kd. Science. 1997 Jan 17;275(5298):343-9. doi: 10.1126/science.275.5298.343. Science. 1997. PMID: 8994024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year